Home » Newsletters » BioWorld

BioWorld

Nov. 3, 1998

View Archived Issues

Appointments And Advancements

Mutating Out Its Cytotoxicity Turns Viral Pathogen Into Potential Vector

Paradigm Genetics, Bayer Sign $40M Herbicide Deal

FDA Approves Kidney Drug; Genzyme To Pay GelTex $15M

Immunex Wins FDA Approval For Enbrel, Launches Quickly